Busan, South Korea

Gyong Suk Kang

This inventor holds 2 USPTO granted patents. Top assignee: The University of Tennessee Research Foundation. Active years: 2007-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gyong Suk Kang. Retrieved from https://idiyas.com/inventor/gyong-suk-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gyong Suk Kang: Innovator in Pharmaceutical Compounds

Introduction

Gyong Suk Kang is a notable inventor based in Pusan, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds aimed at treating cancer. With a total of 2 patents to her name, her work is paving the way for innovative treatments.

Latest Patents

Kang's latest patents focus on substituted tetrahydroisoquinoline compounds. These patents disclose novel compounds, pharmaceutical compositions containing these compounds, methods of making them, and methods of using them to destroy target cells, such as cancer cells. The inventions aim to treat or prevent cancerous conditions, showcasing her commitment to advancing medical science.

Career Highlights

Gyong Suk Kang is affiliated with the University of Tennessee Research Foundation, where she continues her research and development efforts. Her work is characterized by a strong focus on creating effective pharmaceutical solutions that can significantly impact patient care.

Collaborations

Kang has collaborated with esteemed colleagues, including Duane Douglas Miller and Eldon E Geisert, Jr. These partnerships enhance her research capabilities and contribute to the innovative environment in which she works.

Conclusion

Gyong Suk Kang is a pioneering inventor whose work in pharmaceutical compounds is making strides in cancer treatment. Her contributions are vital to the ongoing fight against cancer, and her patents reflect her dedication to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…